Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,735 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Is there an antiandrogen withdrawal syndrome with enzalutamide?
Rodriguez-Vida A, Bianchini D, Van Hemelrijck M, Hughes S, Malik Z, Powles T, Bahl A, Rudman S, Payne H, de Bono J, Chowdhury S. Rodriguez-Vida A, et al. Among authors: hughes s. BJU Int. 2015 Mar;115(3):373-80. doi: 10.1111/bju.12826. Epub 2014 Oct 24. BJU Int. 2015. PMID: 24906049
Immunotherapy for bladder cancer: rediscovering an old friend.
Voskoboynik M, Rudman S, Arkenau HT, Hughes S, Chowdhury S. Voskoboynik M, et al. Among authors: hughes s. BJU Int. 2016 May;117(5):721-4. doi: 10.1111/bju.13330. Epub 2015 Oct 20. BJU Int. 2016. PMID: 26389688 No abstract available.
Advances in advanced prostate cancer - the continuing journey.
Payne H, Davda R, Jones R, Crabb S, Troup J, Hughes S. Payne H, et al. Among authors: hughes s. BJU Int. 2016 Jul;118(1):17-9. doi: 10.1111/bju.13350. Epub 2015 Nov 4. BJU Int. 2016. PMID: 26456636 No abstract available.
Phase III, Double-Blind, Randomized Trial That Compared Maintenance Lapatinib Versus Placebo After First-Line Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 1/2-Positive Metastatic Bladder Cancer.
Powles T, Huddart RA, Elliott T, Sarker SJ, Ackerman C, Jones R, Hussain S, Crabb S, Jagdev S, Chester J, Hilman S, Beresford M, Macdonald G, Santhanam S, Frew JA, Stockdale A, Hughes S, Berney D, Chowdhury S. Powles T, et al. Among authors: hughes s. J Clin Oncol. 2017 Jan;35(1):48-55. doi: 10.1200/JCO.2015.66.3468. Epub 2016 Oct 28. J Clin Oncol. 2017. PMID: 28034079 Free article. Clinical Trial.
Urologic Complications Following Pelvic Radiotherapy.
Lobo N, Kulkarni M, Hughes S, Nair R, Khan MS, Thurairaja R. Lobo N, et al. Among authors: hughes s. Urology. 2018 Dec;122:1-9. doi: 10.1016/j.urology.2018.07.017. Epub 2018 Jul 20. Urology. 2018. PMID: 30036617 Review.
Consensus in Bladder Cancer Research Priorities Between Patients and Healthcare Professionals Using a Four-stage Modified Delphi Method.
Bessa A, Maclennan S, Enting D, Bryan R, Josephs D, Hughes S, Amery S, Khan MS, Malde S, Nair R, Cahill F, Wylie H, Thurairaja R, Chatterton K, Kinsella N, Häggström C, Van Hemelrijck M. Bessa A, et al. Among authors: hughes s. Eur Urol. 2019 Aug;76(2):258-259. doi: 10.1016/j.eururo.2019.01.031. Epub 2019 Jan 31. Eur Urol. 2019. PMID: 30712969 No abstract available.
NICE guidelines on prostate cancer 2019.
Dasgupta P, Davis J, Hughes S. Dasgupta P, et al. Among authors: hughes s. BJU Int. 2019 Jul;124(1):1. doi: 10.1111/bju.14815. BJU Int. 2019. PMID: 31206999 No abstract available.
3,735 results